Literature DB >> 32918361

Do you want to perform endovascular therapy? Perspectives from neurology trainees across Europe.

D R Schreier1, F Di Lorenzo2, F Iodice3, S Shribman4.   

Abstract

BACKGROUND AND
PURPOSE: Endovascular therapy (EVT) has become standard care for acute ischaemic stroke caused by large-vessel occlusion in the anterior circulation. However, access to this treatment in Europe remains poor. The lack of operators is a contributing factor and there is on-going discussion as to whether other specialists, including neurologists, could contribute to the EVT workforce. The question remains whether the next generation of neurologists want to become 'interventional neurologists'. The aim of this study was to address this question.
METHODS: We conducted a short survey within the National Representatives Network (a division of the Resident and Research Fellow Section, European Academy of Neurology) in order to determine the interest of future neurologists in performing EVT.
RESULTS: A total of 1218 responses from 27 European countries were received, with some variation in the number of respondents and results among individual countries. In total, 568 neurology trainees (47%) stated that they would want to be an 'interventional neurologist'.
CONCLUSION: Our findings suggest that neurologists could make a significant contribution to the workforce performing EVT and have important implications for the development and uptake of training programmes in Europe.
© 2020 European Academy of Neurology.

Entities:  

Keywords:  acute ischaemic stroke; endovascular therapy; interventional neurology; mechanical thrombectomy; neurointerventionist; training

Mesh:

Year:  2020        PMID: 32918361     DOI: 10.1111/ene.14519

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  1 in total

1.  The future of neurology after the COVID-19 pandemic according to neurology residents.

Authors:  Tommaso Ercoli; Francesco Barbato; Luca Cuffaro; Francesco Iodice; Michele Romoli; Gioacchino Tedeschi; Alfredo Berardelli; Francesco Di Lorenzo; Alessandro Bombaci
Journal:  Neurol Sci       Date:  2022-10-13       Impact factor: 3.830

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.